UW Research

October 17, 2025

Diversity in Clinical Trials Initiative: 10/17/2025 Special Edition Newsletter from HSD

In this Issue:

Diversity in Clinical Trials Initiative- Language Access Bridge Funding

Resources

In alignment with the Diversity in Clinical Trials Initiative (effective January 1, 2026), the Office of Healthcare Equity (OHCE) is excited to launch the Language Access Bridge Funding Award.

UW Researchers conducting a clinical trial can apply for up to $5,000 to support language access needs—such as document translation, interpreter services, and Communication access real-time translation (CART) services—that will help researchers more effectively recruit and engage underserved populations in clinical trials.

Funding is intended for real-time language access needs (within 30 days)—not for future or unspecified use—as OHCE will be submitting payment for the desired support services for approved applications.

Researchers are required to submit an initial quote for support needs during the application process.

Awardees will be provided with a decision regarding their application within 2 weeks of their submission.

Translation & Interpreter Services – Resources for translation, interpretation, and other communication services or quotes for services are available on this Clinical Trials Resources page (UW Net ID required). Questions about these resources can be directed to uwlaca@uw.edu.

Learn more and apply here: Language Access Bridge Funding – Office of Healthcare Equity

Questions about this resource can be directed to ohce@uw.edu.

 

 

New Reporting Requirements for Diversity in Clinical Trials

Effective January 1, 2026

The University of Washington is implementing new reporting requirements for clinical trials subject to the UW Diversity in Clinical Trials (DCT) policy. These changes support compliance with Washington State’s Diversity in Clinical Trials law (RCW 69.78) and aim to improve the completeness and quality of enrollment data for underrepresented populations.

Key Details:

  • Applies to new clinical trials subject to the UW DCT policy that are submitted to HSD on or after January 1, 2026.
  • Enrollment data must be reported using OnCore, UW’s Clinical Trial Management System (CTMS).
  • Clinical trials reporting solely for compliance with the UW DCT policy have reduced reporting requirements.
  • Clinical trials that are already required to report in OnCore (e.g., oncology studies, studies with UW Medicine billable activities) should adhere to those more robust reporting requirements. For these study teams, no additional training will be required under the DCT pathway.

Compliance Monitoring:

  • Enrollment data, or an indication that no enrollments occurred, must be entered at least annually.
  • CTMS will run monthly reports to identify studies overdue for data entry.
  • Study teams not meeting these reporting requirements will be referred to HSD for follow-up.

Training & Support:

  • Self-paced eLearning module (~20 minutes) via TREE Learning Management System. Training must be completed before study staff can register a clinical trial in OnCore. The training module will be available soon on the CTMS Program Office website.
  • Weekly drop-in office hours:
    • Tuesdays: 10 AM – 12 PM PT
    • Fridays: 12 – 2 PM PT

Upcoming Webinars:

To support onboarding, the CTMS Program Office will host informational webinars on:

  • November 3, 2025- 1:00-2:00 PM PT- Register
  • December 12, 2025- 12:00-1:00 PM PT- Register
  • January 14, 2026- 9:00-10:00 AM PT- Register

For questions contact CTMS@fredhutch.org or hsdinfo@uw.edu.